spacer
home > pmps > winter 2019 > supply forecast
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Forecast

Packaging any pharmaceutical product can be a complex process. Ensuring a drug is packaged in compliance with the marketing authorisation and in a manner appropriate to environmental conditions requires detailed knowledge and experience, as well as having sufficiently trained staff and suitable facilities. This challenge is even greater if multiple drugs are being packaged for multiple markets at a single manufacturing site.

However, packaging products for clinical trials is arguably the most complicated and high-risk type of packaging work carried out in the pharma industry. The additional complexity introduced when there are numerous clinical sites means a detailed understanding of the regulations covering trials, as well as comprehensive knowledge of the study design and clinical protocol, is absolutely essential.

Various considerations in relation to packaging clinical supply will be discussed in this article, including the challenges associated with blinding supply and the impact that looming deadlines, such as that of serialisation, could have on the timescales and the overall cost of clinical trials. Overcoming these complexities through the introduction of new practices, such as just-in-time labelling, will also be outlined.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Newbould is Director of Regulatory Affairs and QP Services at Wasdell Group. He is also one of Wasdell’s QPs for certification to the European market. Colin has over 20 years’ experience in the pharma industry, and, having previously held management positions at PCI Pharma Services, Penn Pharmaceutical Services, and Catalent, Colin also has expertise in facility design and start-up, high potent manufacturing, managing supply chain quality, risk management, and continuous improvement. He holds a BSc in chemistry with analytical chemistry and toxicology, is a current management committee member of the Pharmaceutical and Healthcare Sciences Society, and has previous terms with the Pharmaceutical Quality Group.
spacer
Colin Newbould
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Aptar Pharma Co Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril Portugal

Crystal Lake, Illinois, March 21, 2019 Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.
More info >>

White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement